Cargando…
Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
Autores principales: | Sindal, Manavi D, Yadav, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482901/ https://www.ncbi.nlm.nih.gov/pubmed/34304204 http://dx.doi.org/10.4103/ijo.IJO_626_21 |
Ejemplares similares
-
Commentary: Predicting need for treatment in retinopathy of prematurity – The elusive Holy Grail
por: Sindal, Manavi D
Publicado: (2022) -
Commentary: Parental involvement in retinopathy of prematurity care: An individualized approach
por: Sindal, Manavi D, et al.
Publicado: (2021) -
Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
por: Dogra, Mohit, et al.
Publicado: (2021) -
Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019) -
Commentary: Optimizing surgical training
por: Sindal, Manavi D., et al.
Publicado: (2020)